Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
FBIOP · against 1,336 other Healthcare companies
Ranked #262 of 1,337 · scores higher than 80% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 80–89, including FBIOP · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | FBIOP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | -5.8% | 1.5% | 26% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | -6.2% | 4.2% | 20% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | Not reported | -1.0% | — | — | 20% |
| Book yieldHigher is better · 1,306 reported | 33.0% | 37.9% | 44% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 262 | 15.3B CNY (≈$2.1B) | 80 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 57 |
| 262 | 3.2B CNY (≈$452M) | 80 | 69 |
| 262 | 31.1B TWD (≈$965M) | 80 | 63 |
| 262 | 1.7B USD | 80 | 44 |
| 262 | Unavailable | 80 | 56 |
| 262 | 1.8B USD | 80 | 80 |
| 262 | 2.3B USD | 80 | 52 |
| 262 | 3.2B CHF (≈$3.6B) | 80 | 54 |
| 275 | 3.9B CNY (≈$540M) | 79 | 71 |